HPV test of URine and SElf-collected sampLes For cervical cancer screening study
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0003000
- Lead Sponsor
- Koera University Guro Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
Women with previous abnormal Pap test results (ASCUS, LSIL)
Women between the ages of 20 and 60
Exclusion Criteria
Hysterectomised women
Women with known pregnancy
Non-consenting women
Women that are not able to understand and to sign the informed consent
Women who diagnosed and treated for cervical cancer or other malignancies
Concurrent diseases that are immunosuppressed or require the use of immune-suppressants
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy of HPV test for detecting CIN 2 or worse, by collection method and different HPV test
- Secondary Outcome Measures
Name Time Method Concordance of the presence of HPV16, 18 and other high risk HPV genotyping results applied on urine, self- and clinician-collected samples